Vir Biotechnology(VIR.US)

Event Tracking

Feb24

Vir Biotechnology released FY2025 Q4 earnings on February 23 After-Market EST, actual revenue USD 0 (forecast USD 19.91 M), actual EPS USD 0 (forecast USD -0.408)

00:00

Vir Biotechnology released FY2025 annual earnings on February 23 After-Market (EST), actual revenue USD 68.56 M (forecast USD 20.78 M), actual EPS USD -3.1618 (forecast USD -3.28)

00:00

Feb16

Vir Biotechnology to release FY2025 Q4 earnings on February 23 After-Market EST, forecast revenue USD 19.91 M, EPS USD -0.408

00:23

Jan12

Vir Biotechnology Provides Updates on Chronic Hepatitis B and Oncology Projects

13:09

Dec12

H.C. Wainwright Maintains Buy Rating for Vir Biotechnology with a Price Target of $15.00

11:42

Nov9

Vir Biotechnology Reports Positive Results for Chronic Hepatitis Delta Treatment SOLSTICE Trial